The invention relates to a tunnel device that is used to redirect a medical device within subcutaneous tissue during insertion or implantation into a patient.
The insertion of subcutaneous implantable devices, such as cardio defibrillators, can be very difficult due to the tortuous path that the device must traverse in order to be placed at the desired location. The device must be redirected several times, some times turning as much as ninety degrees inside subcutaneous tissue. This process is especially difficult in pediatric and neonatal patients, whose smaller anatomy adds to the difficulty in performing the procedure.
It would be beneficial to provide a tunneler to assist in guiding subcutaneous implantable devices without having to perform an incision to turn the device to redirect it during insertion.
This Summary is provided to introduce a selection of concepts in a simplified form that are further described below in the Detailed Description. This Summary is not intended to identify key features or essential features of the claimed subject matter, nor is it intended to be used to limit the scope of the claimed subject matter.
In one embodiment, the present invention is a tunnel device for a subcutaneous implantable device. The tunnel device includes an elongate outer sleeve having an open proximal end and an open distal end. An elongate outer trough has a trough proximal end, a trough distal end, and a concave cradle extending between the trough proximal end and the trough distal end. The outer trough is sized to slidingly fit inside outer sleeve such that the outer sleeve is slidable externally along the outer trough. An inner glide rests in the cradle. The inner glide includes an inner trough, a guide arm connected to a distal end of the inner trough, and a pivot arm connected to a distal end of the guide arm.
The accompanying drawings, which are incorporated herein and constitute part of this specification, illustrate the presently preferred embodiments of the invention, and, together with the general description given above and the detailed description given below, serve to explain the features of the invention. In the drawings:
In the drawings, like numerals indicate like elements throughout. Certain terminology is used herein for convenience only and is not to be taken as a limitation on the present invention. The terminology includes the words specifically mentioned, derivatives thereof and words of similar import. As used herein, the term“proximal” means a direction toward to the interventionist inserting the inventive tunneler and the term “distal” means a direction away from the interventionist inserting the inventive tunneler.
The embodiments illustrated below are not intended to be exhaustive or to limit the invention to the precise form disclosed. These embodiments are chosen and described to best explain the principle of the invention and its application and practical use and to enable others skilled in the art to best utilize the invention.
Reference herein to “one embodiment” or “an embodiment” means that a particular feature, structure, or characteristic described in connection with the embodiment can be included in at least one embodiment of the invention. The appearances of the phrase “in one embodiment” in various places in the specification are not necessarily all referring to the same embodiment, nor are separate or alternative embodiments necessarily mutually exclusive of other embodiments. The same applies to the term “implementation.”
As used in this application, the word “exemplary” is used herein to mean serving as an example, instance, or illustration. Any aspect or design described herein as “exemplary” is not necessarily to be construed as preferred or advantageous over other aspects or designs. Rather, use of the word exemplary is intended to present concepts in a concrete fashion.
Additionally, the term “or” is intended to mean an inclusive “or” rather than an exclusive “or”. That is, unless specified otherwise, or clear from context, “X employs A or B” is intended to mean any of the natural inclusive permutations. That is, if X employs A; X employs B; or X employs both A and B, then “X employs A or B” is satisfied under any of the foregoing instances. In addition, the articles “a” and “an” as used in this application and the appended claims should generally be construed to mean “one or more” unless specified otherwise or clear from context to be directed to a singular form.
As shown in the Figures, the present invention is a tunnel device (“device 100”) for implanting a defibrillator coil or electrode 180 of a subcutaneous implantable cardioverter-defibrillator (S-ICD) according to an exemplary embodiment of the present invention. Device 100 is used to turn electrode 180 about 90 degrees within the chest cavity of a patient, without having to perform an incision at the turning location.
Referring to
An elongate outer trough 120 is sized to slidingly fit inside outer sleeve 110 so that outer sleeve 110 can be slid and directed externally along outer trough 120, such as in a distal direction, after device 100 is inserted at a desired location. Outer trough 120 has a proximal end 122, a distal end 124, and a concave cradle 126 extending between the proximal end 122 and the distal end 124. In an exemplary embodiment, cradle 126 has a generally semi-circular cross section and extends from proximal end 122 toward distal end 124, although those skilled in the art will recognize that cradle 126 can have other shapes. Cradle 126 is sized to allow inner glide 140 to rest in cradle 126. Further, proximal end 122 can have a generally annular cross section, if desired.
Distal end 124 includes a stop 128 that extends above cradle 126. Stop 128 acts as a positive brake to limit operation of an inner glide 140, as will be discussed below. A pivot 130 extends across trough 126 just proximally of stop 128. Additionally, the bottom surface of outer trough 120 proximal of stop 128 includes a longitudinally extending slot 132.
Inner glide 140 slidingly rests inside outer trough 120 and includes a proximal end 142 and a distal end 144. Proximal end 142 can be manipulated by the interventionist to longitudinally translate inner glide 140 along outer trough 120.
Inner glide 140 includes, from proximal end 142 to distal end 144, an inner trough 146, a guide arm 148 connected to a distal end of inner trough 146, and a pivot arm 150 connected to a distal end of guide arm 148.
Pivot arm 150 includes a proximal end 152 and a distal end 154. Distal end 154 has a generally blunted tip 156 that can be used as a tunneler to dissect tissue as device 100 is being advanced subcutaneously. A pivot point 158 is located proximally of tip 156 and is pivotally connected to pivot 130 so that pivot arm 150 can pivot about pivot 130. Distal end 154 of pivot arm 150 can be reduced in lateral cross section such that distal end 154 of pivot arm 150 can fit into slot 132 when pivot arm 150 is pivoted. Optionally, pivot arm 150 can have a teardrop shaped cross section as shown in
In an exemplary embodiment, pivot arm 150 is solid, although those skilled in the art will recognize that pivot arm 150 can include a cannula (not shown) to allow for the passage of fluids through pivot arm 150, if so desired.
Pivot arm 150 is connected to guide arm 148 via a living hinge 160. In an exemplary embodiment, as shown in
The distal end 164 is tapered with a slope from top to bottom in a proximal-to-distal direction to match the slope of proximal end 152 of pivot arm 150 such that, when inner glide 140 is being advanced with outer trough 120, distal end 164 of guide arm 148 extends under proximal end 152 of pivot arm 150. In an exemplary embodiment, the slope of tapered proximal end 152 of pivot arm 150 and tapered distal end 164 of guide arm 148 are both about 45 degrees.
Inner trough 146 includes a proximal end 172, a distal end 174, and a concave cradle 176 extending between the proximal end 172 and the distal end 174. In an exemplary embodiment, cradle 176 has a generally semi-circular cross section and extends from proximal end 172 to distal end 174, although those skilled in the art will recognize that cradle 176 can have other shapes. Cradle 176 is sized to allow electrode 180 to rest inside cradle 176 as device 100 is being inserted.
Proximal end 162 of guide arm 148 is connected to distal end 174 of cradle 176 via a living hinge 178. Proximal end 162 is tapered with a slope from top to bottom in a distal-to-proximal direction and distal end 174 of inner trough 146 is tapered with a slope from top to bottom in a proximal-to-distal direction such that a generally V-shaped gap is formed between proximal end 162 and distal end 174. In an exemplary embodiment, both proximal end 162 and distal end 174 are tapered about 22½ degrees.
Referring to
Electrode 180 also includes a sheath 190 surrounding electrode 180. Sheath 190 can be peeled away after electrode 180 is deployed. Sheath 190 also includes a second portion 192 of the releasable connector 169, such as a hook and loop fastener, that is releasably engaged with the first portion 168 of the releasably connector, in order to maintain electrode 180 with device 100 as device 100 is being deployed.
Optionally, as shown in
The device 100 allows a surgeon to utilize a single incision to place a subcutaneous coil for S-ICD without the need for additional incisions. The device 100 allows tunneling of any device (coil, tube, etc) in the subcutaneous portion and acute angle adjustments.
Prior to inserting device 100, a pre-operative chest X-ray is performed to determine that the patient is acceptable for S-ICD. The patient is marked in the left chest prepped and draped in standard surgical fashion and R2 pads. An incision is made subcutaneously in the inframammary crease and meticulous hemostasis is obtained. A dissection is carried down to the fascial plane, leaving the muscle intact.
Next, device 100 is passed onto the sterile field and fluoroscopy can be used to ascertain the incision to the bottom of the sternum 50, as shown in
The device 100 is now deployed, creating the angle (90 degrees) as shown in
Next the electrode 180 and inner sheath 190 (metal reinforced peel away) is advanced in a cephalad direction while using fluoroscopy. Electrode 180 is advanced distally along inner trough 146 until distal tip 182 engages guide arm 148. Guide arm 148 redirects distal tip 182 along guide arm 148 until electrode 180 is extending at an angle of about 90 degrees relative to the length of outer trough 120 and advancing upwardly along the spine to a desired location until the barbed tip 182 reaches the top of the xiphoid process of the sternum 50, as shown by arrow C in
After electrode tip 182 has been advanced to a desired location, the interventionist retracts inner guide 140 proximally, thereby pivoting pivot arm 150 and guide arm 148 into outer trough 120. The first portion 168 of the releasable connector 169 releases from the second portion 192 of the releasable connector 169, thereby releasing electrode 180 from device 100, as shown in
The living hinges 160, 178 on either side of guide body 166 have memory to favor a 90 degree angle of pivot arm 150 relative to outer trough 120 is maintained and has an outer covering of releasable connector 169 to favor engraftment of surrounding fascia and adipose tissue. With two points of fixation (barbed distal tip 182 and second part 192 of releasable connector 169) and deployment using fluoroscopy, the surgeon will have confidence that the electrode 180 will remain in position to complete the procedure as shown in
The surgeon now connects the electrode or lead 180 to the ICD battery device and sutures the battery device to the fascia. The pocket is irrigated with antibiotic solution. The procedure is completed by suturing the fascia, dermis, and skin closed using appropriate suture. A sterile dressing is then applied.
It is known that transeptal puncture is difficult. The device 100 can be used for angle creation of an intravascular device. An example of a transeptal puncture using device 100 is provided and shown schematically in
First, needle access is provided in the groin. An introducer sheath is used. Under fluoroscopy and/or palpation, a guide wire 220 is advanced to the superior vena cava. The device 100 is advanced over the wire to the superior vena cava 60 and the guide wire 220 is removed. The inner guide 140 is advanced, while using fluoroscopy, to generate the angle needed. The outer sheath or introducer is not moved.
Next, the guide wire 220 and wire reinforced sheath are advanced, using fluoroscopy, to the septum of the heart. The guidewire 220 and wire reinforced sheath 190 are advanced until traversing the septum (from the right atrium RA to the left atrium LA). The outer trough 120 is advanced, removing the acute angle. The entire device 100 is removed by withdrawing the device 100 proximally along the guide wire 220, with the guide wire 220 and wire reinforced sheath 190 remaining in place. The wire reinforced sheath 190 is then removed and can be peeled away at the groin if needed.
The guidewire 220 at this point goes from venous access in the groin to the inferior vena cava 60 to the right atrium RA to the left atrium LA for “left heart access”. This procedure is suitable for mitral valve procedures, left atrial ablations, or any other indications.
It will be appreciated by those skilled in the art that changes could be made to the embodiments described above without departing from the broad inventive concept thereof. It is understood, therefore, that this invention is not limited to the particular embodiments disclosed, but it is intended to cover modifications within the spirit and scope of the present invention as defined by the appended claims.
The present application claims the benefit of U.S. Provisional Patent Application Ser. No. 63/186,867, filed on May 11, 2021, which is incorporated herein by reference in its entirety.
Filing Document | Filing Date | Country | Kind |
---|---|---|---|
PCT/US22/27974 | 5/6/2022 | WO |
Number | Date | Country | |
---|---|---|---|
63186867 | May 2021 | US |